BioBreakthroughs – Details, episodes & analysis

Podcast details

Technical and general information from the podcast's RSS feed.

BioBreakthroughs

Slice of Healthcare LLC

News

Science

Frequency: 1 episode/17d. Total Eps: 49

Welcome to BioBreakthroughs, the podcast that delves deep into the world of biotech and pharmaceuticals to bring you the latest and most exciting advancements in the field. Join us as we explore groundbreaking discoveries, cutting-edge research, and game-changing innovations that are shaping the future of healthcare. Produced by Slice of Healthcare.

Read moreCollapse

RSS

Apple

Recent rankings

Latest chart positions across Apple Podcasts and Spotify rankings.

Apple Podcasts

🇨🇦 Canada - businessNews
07/04/2026
#100
🇨🇦 Canada - businessNews
06/04/2026
#78
🇨🇦 Canada - businessNews
05/04/2026
#75

Spotify

No recent rankings available

Shared links between episodes and podcasts

Links found in episode descriptions and other podcasts that share them.

See all

https://www.linkedin.com/company/sliceofhealthcare/
48 shares
https://www.linkedin.com/company/advarra/
4 shares
https://www.linkedin.com/company/lokavant/
4 shares

https://www.youtube.com/channel/UCPuxsHtzFktm1XezuJp-KoA
2 shares
https://www.youtube.com/@UCPuxsHtzFktm1XezuJp-KoA
2 shares

RSS feed quality and score

Technical evaluation of the podcast's RSS feed quality and structure.

See all

RSS feed quality

To improve

Score global : 63%

Publication history

Monthly episode publishing history over the past years.

Year

Latest published episodes

Recent episodes with titles, durations, and descriptions.

See all

#50 - Frank Bedu-Addo, President and CEO at PDS Biotechnology Corporation

Episode 50

Tuesday, August 19, 2025 • Duration 20:37

Join us on the latest episode! Our Guest: Frank Bedu-Addo, President and CEO at PDS Biotechnology Corporation.

What you'll get out of this episode:

PDS Biotechnology targets the key limitations of CAR T and cancer vaccine therapies using lipid nanoparticle-based immunotherapy.
Their lead candidate, PDS0101, demonstrated over 2x improvement in survival for HPV-positive head and neck cancer.
The platform technology shows consistent efficacy across multiple independent Phase 2 trials.
Late-stage clinical programs focus on HPV16+ head and neck cancer, with additional trials for colorectal, prostate, and MUC1+ cancers.

To Learn More About Our Guest And Their Company:
Guest LinkedIn https://www.linkedin.com/in/frank-bedu-addo-4797947/
Company LinkedIn https://www.linkedin.com/company/pds-biotechnology-corporation/
Website https://www.pdsbiotech.com/

Our sponsor for this episode are:
Sage Growth Partners https://sage-growth.com/

BioBreakthroughs is part of the Slice of Healthcare podcast network:
LinkedIn: https://www.linkedin.com/company/sliceofhealthcare/

Read moreCollapse

#49 - Michael Demurjian, Founder & CEO at Aspargo Laboratories

Episode 49

Tuesday, May 27, 2025 • Duration 16:33

Join us on the latest episode! Our Guest: Michael Demurjian, Founder & CEO at Aspargo Laboratories.

What you'll get out of this episode:

Aspargo tackles inefficiencies in pill-based drug delivery through innovative oral suspensions.
The company’s patented technology improves absorption via buccal and GI routes.
First commercial product, HisQ (oral spray sildenafil), delivers rapid ED treatment in just 10 minutes—even on a full stomach.
Future products include sprays for weight loss and hair loss, launching via a telehealth platform.
Upcoming smart dispenser connects with physicians and caregivers for enhanced adherence and monitoring.

To Learn More About Our Guest And Their Company:
Guest LinkedIn https://www.linkedin.com/in/michael-demurjian-02868113/
Company LinkedIn https://www.linkedin.com/company/aspargo-laboratories-inc/
Website https://aspargolabs.com/

Our sponsor for this episode are:
Sage Growth Partners https://sage-growth.com/

BioBreakthroughs is part of the Slice of Healthcare podcast network:
LinkedIn: https://www.linkedin.com/company/sliceofhealthcare/

Read moreCollapse

#40 - Christine Senn, PhD, SVP of Site-Sponsor Innovation at Advarra & Rohit Nambisan, Co-Founder and CEO at Lokavant

Episode 40

Wednesday, May 29, 2024 • Duration 17:40

Join us on the latest episode! Our Guests: Christine Senn, PhD, the SVP of Site-Sponsor Innovation at Advarra & Rohit Nambisan, Co-Founder and CEO at Lokavant.

What you'll get out of this episode:

Rohit Nambisan discusses Lokavant's approach to leveraging AI in clinical trial feasibility.
Christine Senn highlights the importance of thorough feasibility processes in rare disease trials.
The need for diverse site participation and data inputs to improve trial accuracy and efficiency.
The role of AI and technology in enhancing clinical trial processes.

To learn more about our guests and their companies:
Christine's LinkedIn https://www.linkedin.com/in/christinesenn/
Rohit's LinkedIn https://www.linkedin.com/in/rohitnambisan/

Advarra LinkedIn https://www.linkedin.com/company/advarra/
Lokavant LinkedIn https://www.linkedin.com/company/lokavant/

Advarra Website https://www.advarra.com/
Lokavant Website https://www.lokavant.com/en-us/

Our sponsor for this episode is:
Sage Growth Partners https://sage-growth.com/

BioBreakthroughs is part of the Slice of Healthcare podcast network:
LinkedIn: https://www.linkedin.com/company/sliceofhealthcare/

#39 - Dr. Sam Clark, Founder and CEO at Terran Biosciences

Episode 39

Wednesday, May 15, 2024 • Duration 15:17

Join us on the latest episode! Our Guest: Dr. Sam Clark, Founder and CEO at Terran Biosciences.

What you'll get out of this episode:

Revolutionizing Treatments: Dr. Sam Clark discusses Terran Biosciences' mission to innovate treatments for neurological and psychiatric conditions.
Innovative Drug Development: The company focuses on creating new mechanisms for treating depression, bipolar disorder, and schizophrenia.
Smaller, Agile Teams: Terran Biosciences operates with a flat structure, utilizing highly trained experts to solve complex problems.
Addressing Patent Monopolies: The company aims to break patent monopolies in pharma through innovative approaches and pro-drug strategies.
Exciting Developments: Dr. Clark teases upcoming announcements, including long-acting and improved drug forms.

To learn more about our guests and their companies:
LinkedIn https://www.linkedin.com/in/sam-clark-md-phd-133139199/
Company LinkedIn https://www.linkedin.com/company/terran/
Website https://terranbiosciences.com/

Our sponsor for this episode are:
Sage Growth Partners https://sage-growth.com/

BioBreakthroughs is part of the Slice of Healthcare podcast network:
LinkedIn: https://www.linkedin.com/company/sliceofhealthcare/

#38 - Dr. Michael Kyle, SVP & Chief Medical Officer at Currax Pharmaceuticals

Episode 38

Wednesday, May 8, 2024 • Duration 22:02

Join us on the latest episode! Our Guest: Dr. Michael Kyle, SVP & Chief Medical Officer at Currax Pharmaceuticals.

What you'll get out of this episode:

Dr. Michael Kyle's Background: Insights into his journey from medical practice to becoming SVP & Chief Medical Officer of Currax Pharmaceuticals.
Understanding Obesity: A discussion on different types of obesity and the importance of tailored treatments.
Global Perspectives: Comparing how the U.S. and European countries handle obesity and the lessons to be learned.
Evolving Treatments: The parallel evolution of hypertension and obesity treatments.
Behavioral Approaches: The importance of sustainable lifestyle changes and behavior modification in addressing obesity.

To learn more about our guests and their companies:
LinkedIn https://www.linkedin.com/in/michael-l-kyle/
Company LinkedIn https://www.linkedin.com/company/currax-pharmaceuticals-llc/
Website https://www.curraxpharma.com/

Our sponsor for this episode are:
Sage Growth Partners https://sage-growth.com/

BioBreakthroughs is part of the Slice of Healthcare podcast network:
LinkedIn: https://www.linkedin.com/company/sliceofhealthcare/

Read moreCollapse

#37 - Colin Weller, VP & GM Evidence Platform at Medable

Episode 37

Wednesday, April 17, 2024 • Duration 16:45

Join us on the latest episode! Our Guest: Colin Weller, VP & GM of Evidence Platform at Medable.

What you'll get out of this episode:

Introduction of Colin Weller: Vice President and GM of Evidence Platform at Medable, Colin Weller discusses his role in advancing clinical research technology to streamline drug approvals.
Challenges in Drug Development: Weller details the stagnant pace of drug development, highlighting the industry's need for innovation to improve efficiency and reduce costs.
Medable's Ambitious Goals: Aiming to increase the number of drugs approved annually by tenfold through advanced SAS technology and AI, setting a new industry standard.
Innovations in Clinical Trials: Medable has already cut study startup times by 50%, utilizing AI and automation to overhaul traditional processes.
Future of Digital Clinical Trials: Weller predicts significant advancements in decentralized and digital trials, enhancing patient accessibility and data quality.

To learn more about our guests and their companies:
LinkedIn: https://www.linkedin.com/in/colin-weller-294ab58/
Company LinkedIn: https://www.linkedin.com/company/medable-inc-/
Website: https://www.medable.com/

Our sponsor for this episode are:
Sage Growth Partners https://sage-growth.com/

BioBreakthroughs is part of the Slice of Healthcare podcast network:
LinkedIn: https://www.linkedin.com/company/sliceofhealthcare/

#36 - Stella K. Vnook, CEO at Likarda

Episode 36

Wednesday, March 20, 2024 • Duration 19:04

Join us on the latest episode! Our Guest: Stella K. Vnook, CEO at Likarda.

What you'll get out of this episode:

Stella Vnook, CEO of Likarda, discusses her transition from a science background to the business side of biotech and her journey to becoming CEO.
Likarda specializes in core-shell spherification, creating beads with cells for targeted drug delivery, improving viability and efficacy.
The company aims to enhance cell therapies, especially in liver cells and hormone therapy, and simplify cell transport logistics.
Likarda's future goals include launching off-the-shelf products for osteoarthritis and advancing partnerships in cell therapy and regenerative medicine.
Funding strategies and future plans involve a Series A funding round, non-dilutive funding, and efficient use of resources to scale up and innovate.

To learn more about our guests and their companies:
LinkedIn: https://www.linkedin.com/in/vnook/
Company LinkedIn: https://www.linkedin.com/company/likarda-llc/
Website: https://likarda.com/

Our sponsor for this episode are:
Sage Growth Partners https://sage-growth.com/

BioBreakthroughs is part of the Slice of Healthcare podcast network:
LinkedIn: https://www.linkedin.com/company/sliceofhealthcare/

Read moreCollapse

#35 - Samantha Dale Strasser, CEO & Co-Founder at Pepper Bio

Episode 35

Wednesday, March 13, 2024 • Duration 19:52

Join us on the latest episode! Our Guest: Samantha Dale Strasser, CEO & Co-Founder at Pepper Bio.

What you'll get out of this episode:

Samantha Dale Strasser, co-founder and Chief Science Officer of Pepper Bio, shares her transition from academia to entrepreneurship, driven by a personal mission to change healthcare outcomes.
Pepper Bio, located in Boston, leverages transomics to integrate multiple data sets for precision medicine, aiming to treat diseases that are currently untreatable.
Strasser’s focus is on developing treatments for challenging diseases, with an emphasis on oncology, inflammatory diseases, and neurodegenerative disorders.
Pepper Bio’s approach in drug discovery combines its own pipeline development with strategic partnerships, speeding up the process of bringing new treatments to the clinic.
The company has made significant strides in identifying novel targets and shelved assets, leading to a high success rate in in vivo model validations.

To learn more about our guests and their companies:
LinkedIn: https://www.linkedin.com/in/samantha-dale-strasser/
Company LinkedIn: https://www.linkedin.com/company/pepperbio/
Website: https://pepper.bio/

Our sponsor for this episode are:
Sage Growth Partners https://sage-growth.com/

BioBreakthroughs is part of the Slice of Healthcare podcast network:
LinkedIn: https://www.linkedin.com/company/sliceofhealthcare/

#34 - Cary Claiborne, CEO of Adial Pharmaceuticals

Episode 34

Wednesday, February 14, 2024 • Duration 14:44

Join us on the latest episode! Our Guest: Cary Claiborne, CEO of Adial Pharmaceuticals.

What you'll get out of this episode:

Meet Cary Claiborne: Discover the visionary CEO behind Adial Pharmaceuticals.
Understanding AD04: Dive into the science of this promising new treatment for alcohol use disorder.
The Impact of Alcohol Use Disorder: A closer look at the challenges and the need for better treatments.
A Glimpse into the Future: Explore how AD04 could revolutionize addiction treatment beyond alcohol use disorder.
Adial's Mission and Vision: Hear directly from Claiborne about the company's path forward and commitment to innovation.

To learn more about our guests and their companies:
LinkedIn: https://www.linkedin.com/in/cary-claiborne-sr-84a2217/
Company LinkedIn: https://www.linkedin.com/company/adialpharma/
Website: https://www.adial.com/

Our sponsor for this episode are:
Sage Growth Partners https://sage-growth.com/

BioBreakthroughs is part of the Slice of Healthcare podcast network:
LinkedIn: https://www.linkedin.com/company/sliceofhealthcare/

Read moreCollapse

#33 - Marcio Souza, CEO of Praxis Precision Medicines

Episode 33

Monday, February 5, 2024 • Duration 14:37

Join us on the latest episode! Our Guest: Marcio Souza, CEO of Praxis Precision Medicines.

What you'll get out of this episode:

Discussion on innovative CNS drug development on BioBreakthroughs podcast.
Learn about Praxis' genetics-inspired approach to tackling complex brain diseases.
Souza highlights the challenges and opportunities in CNS treatment, including the impactful EMBOLD and EMBRAVE studies.
Discover Praxis Precision Medicines' future prospects and their commitment to revolutionizing patient care in the CNS field.

To learn more about our guests and their companies:
LinkedIn: https://www.linkedin.com/in/marcio-souza-2b02837/
Company LinkedIn: https://www.linkedin.com/company/praxis-precision-medicines-inc/
Website: https://praxismedicines.com/

Our sponsor for this episode are:
Sage Growth Partners https://sage-growth.com/

BioBreakthroughs is part of the Slice of Healthcare podcast network:
LinkedIn: https://www.linkedin.com/company/sliceofhealthcare/

Read moreCollapse

BioBreakthroughs – Details, episodes & analysis

Podcast details

Recent rankings

Apple Podcasts

Spotify

Shared links between episodes and podcasts

RSS feed quality and score

Publication history

Latest published episodes

Related Shows Based on Content Similarities

Apple Podcasts

Spotify

Related Shows Based on Content Similarities

BioBreakthroughs – Details, episodes & analysis

Podcast details

Recent rankings

Apple Podcasts

Spotify

Shared links between episodes and podcasts

Other54

LinkedIn57

Youtube2

RSS feed quality and score

Publication history

Latest published episodes

Similar podcasts and content

Related Shows Based on Content Similarities

Apple Podcasts

Spotify

Related Shows Based on Content Similarities

Other54

LinkedIn57

Youtube2